A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Clinical trial NCT02912949 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02912949
Sponsor: Partner Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumours Harboring NRG1 Fusion NSCLC Harboring NRG1 Fusion Pancreatic Cancer Harboring NRG1 Fusion NRG1 Fusion

Start date: 2015-01-01
Primary completion: 2026-12-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.